Manchester Keith S's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Sep 26, 2024
- Accession no.
- 0000950170-24-109733
- Filed
- Sep 26, 2024
- Trade date
- Sep 24-25, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $5.87M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manchester Keith SCIK 0001244828 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2024 | Common Shares | SSaleDisposed | −368,052 | $11.63 | −$4,280,444.76 | 1,412,126 | Direct | |
| Sep 25, 2024 | Common Shares | SSaleDisposed | −134,948 | $11.77 | −$1,588,337.96 | 1,277,178 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.